Total Valuation
Insmed has a market cap or net worth of CHF23.88B. The enterprise value is CHF22.76K.
Market CapCHF23.88B
Enterprise ValueCHF22.76K
Share Statistics
Insmed has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders0.71%
Owned by Institutions3.30%
Financial Efficiency
Insmed’s return on equity (ROE) is -1.73 and return on invested capital (ROIC) is -64.84%.
Return on Equity (ROE)-1.73
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-64.84%
Return on Capital Employed (ROCE)-0.66
Revenue Per Employee364.44K
Profits Per Employee-767.29K
Employee Count1,664
Asset Turnover0.27
Inventory Turnover0.95
Valuation Ratios
The current PE Ratio of Insmed is ―. Insmed’s PEG ratio is -1.80.
PE Ratio―
PS Ratio61.31
PB Ratio50.31
Price to Fair Value50.31
Price to FCF-38.43
Price to Operating Cash Flow-36.99
PEG Ratio-1.80
Income Statement
In the last 12 months, Insmed had revenue of 606.42M and earned -1.28B in profits. Earnings per share was -6.41.
Revenue606.42M
Gross Profit481.55M
Operating Income-1.18B
Pretax Income-1.27B
Net Income-1.28B
EBITDA-1.17B
Earnings Per Share (EPS)-6.41
Cash Flow
In the last 12 months, operating cash flow was -778.92M and capital expenditures -58.75M, giving a free cash flow of -837.67M billion.
Operating Cash Flow-778.92M
Free Cash Flow-837.67M
Free Cash Flow per Share-10.00T>
Dividends & Yields
Insmed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta4.61
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Insmed upcoming earnings date is Oct 22, 2026, TBA (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateOct 22, 2026
Ex-Dividend Date―
Financial Position
Insmed as a current ratio of 3.83, with Debt / Equity ratio of 4.80%
Current Ratio3.83
Quick Ratio3.54
Debt to Market Cap0.02
Net Debt to EBITDA-0.22
Interest Coverage Ratio-14.04
Taxes
In the past 12 months, Insmed has paid 5.03M in taxes.
Income Tax5.03M
Effective Tax Rate>-0.01
Enterprise Valuation
Insmed EV to EBITDA ratio is -31.96, with an EV/FCF ratio of -38.69.
EV to Sales61.74
EV to EBITDA-31.96
EV to Free Cash Flow-38.69
EV to Operating Cash Flow-40.04
Balance Sheet
Insmed has CHF1.16B in cash and marketable securities with CHF747.28M in debt, giving a net cash position of CHF413.04M billion.
Cash & Marketable SecuritiesCHF1.16B
Total DebtCHF747.28M
Net CashCHF413.04M
Net Cash Per ShareCHF10.00T>
Tangible Book Value Per ShareCHF2.36
Margins
Gross margin is 83.27%, with operating margin of -194.04%, and net profit margin of -210.54%.
Gross Margin83.27%
Operating Margin-194.04%
Pretax Margin-209.71%
Net Profit Margin-210.54%
EBITDA Margin-193.18%
EBIT Margin-195.90%
Analyst Forecast
The average price target for Insmed is CHF162.84, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetCHF162.84
Price Target Upside― Upside
Analyst ConsensusStrong Buy
Analyst Count19
Revenue Growth Forecast―
EPS Growth Forecast―